China Orders Cereulide Testing Amid Global Infant Formula Recalls

China's State Administration for Market Regulation has mandated that infant formula manufacturers conduct tests for cereulide, a toxin linked to precautionary recalls by major food companies, including Nestle SA and Danone SA. This directive follows Nestle's detection of cereulide in baby formula sourced from ARA oil produced by Cabio Biotech Wuhan Co., a significant supplier in the global infant formula market. Although no poisoning cases have been reported in China, the urgency of the situation has prompted local governments to enhance oversight of safety and quality standards.

Bloomberg

Cabio Biotech Wuhan Co. has emerged as one of the largest producers of ARA oil, supplying not only Nestle and Danone but also local companies such as China Feihe Ltd. and Junlebao Dairy Group Co. The company's rapid growth has disrupted the previously established dominance of Dutch chemical maker DSM-Firmenich AG in the ARA ingredient market. The fallout from the cereulide detection has led to a significant decline in Cabio's stock value, which has dropped 16% this year.

Bloomberg

In response to the situation, China has taken steps to tighten regulatory oversight. The market regulator's order emphasizes the need for manufacturers to enforce strict controls on raw materials and product releases. While Nestle has expanded its recall efforts beyond Europe to include parts of Asia and the Americas, Danone and other producers have also withdrawn products from multiple markets. Analysts suggest that these recalls could impact the reputations of both companies and lead to more stringent regulations across the global infant formula supply chain.

Bloomberg

Despite the recalls and regulatory actions, market reactions have been relatively stable. Following the announcement that no poisoning cases had been confirmed in China, shares of Danone rose by 4.72%, and Nestle's shares increased by 1.39%. Barclays analyst Warren Ackerman noted that the market seems to have already accounted for the effects of Nestle's global recalls, indicating a potential shift towards recovery.

Bloomberg

While no confirmed illnesses have been linked to the recalls, the situation has raised concerns among consumers and investors regarding food safety in the infant formula sector. Regulatory bodies in various countries are investigating potential cases related to the toxin, highlighting the need for ongoing vigilance in food safety standards.

Bloomberg

• “We believe the market has already priced in the impact of Nestlé’s global recalls, and we can hopefully now move on,” — Warren Ackerman, Analyst at Barclays

Bloomberg

As the situation develops, it remains to be seen how the stricter regulations will affect the global infant formula supply chain and whether further recalls will be necessary. The ongoing investigations into potential poisoning cases will likely influence future regulatory measures and consumer confidence in the industry.

Bloomberg